News
GDRX
7.10
+1.28%
0.09
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX)
Law Offices of Howard G. Smith reminds investors of the upcoming June 21, 2024 deadline to file a lead plaintiff motion in the case of GoodRx Holdings, Inc. Investors who purchased GoodR x common stock between September 23, 2020, and November 8, 2022 are encouraged to contact the Law Offices.
Barchart · 3d ago
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of GoodRx Holdings, Inc. (GDRX) Investors
A class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired GoodRx Holdings, Inc. Common stock between September 23, 2020, and November 8, 2022. GoodRX investors have until June 21, 2024 to file a lead plaintiff motion. In May 2022, Goodrx announced that it withdrew its fiscal 2022 guidance. The complaint alleges that the company made false and misleading statements.
Barchart · 4d ago
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of GoodRx Holdings, Inc. (GDRX) Investors
GoodRx Holdings, Inc. Investors have until June 21, 2024 to file a lead plaintiff motion. A class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired GoodRx common stock. The Company withdrew its fiscal 2022 guidance and GoodRX’s stock price fell 25.9%.
Barchart · 5d ago
GoodRx Holdings, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the GDRX Securities Class Action
Robbins LLP reminds investors that a shareholder filed a class action on behalf of GoodRx Holdings, Inc. Shareholders between September 23, 2020 and November 8, 2022. GoodRX operates a price comparison platform for prescription drugs. Robbins LLP is Investigating the Allegations that Goodrx Holdings,. Inc. Misrepresented its Business Prospects.
Barchart · 6d ago
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of GoodRx Holdings, Inc. (GDRX) Investors
Law Offices of Howard G. Smith announces a class action lawsuit has been filed on behalf of investors who purchased GoodRx Holdings, Inc. Common stock between September 23, 2020, and November 8, 2022. GoodRX investors have until June 21, 2024 to file a lead plaintiff motion. The lawsuit alleges that Goodrx made false and/or misleading statements to investors.
Barchart · 6d ago
Weekly Report: what happened at GDRX last week (0422-0426)?
Weekly Report · 6d ago
GDRX INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GoodRx class action lawsuit seeks to represent purchasers or acquirers of GoodRx Holdings, Inc. Common stock between September 23, 2020 and November 8, 2022. You have until June 21, 2024 to seek appointment as lead plaintiff of the GoodRX class action suit. Goodrx operates a price comparison platform for prescription drugs.
Barchart · 6d ago
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GDRX
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of GoodRx Holdings, Inc. A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 21, 2024.
Barchart · 04/26 15:49
Investors in GoodRx Holdings, Inc. Should Contact Levi & Korsinsky LLP Before June 21, 2024 to Discuss Your Rights – GDRX
TipRanks · 04/26 00:00
GDRX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GoodRx Holdings, Inc. Class action lawsuit seeks to represent purchasers or acquirers of GoodRx common stock between September 23, 2020 and November 8, 2022. If you wish to serve as lead plaintiff of the GoodRX class action suit, please contact Robbins Geller Rudman & Dowd LLP. Goodrx operates a price comparison platform for prescription drugs. The GoodR x lawsuit alleges the company made false and/or misleading statements.
Barchart · 04/25 07:35
GoodRx Holdings Insider Ups Holding During Year
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) insiders have been buying shares in the last year. The biggest single purchase by an insider was by Scott Wagner for US$677k. GoodRx Holding insiders own about 3.1% of the company. Over the last 12 months, Goodrx Holdings insiders have bought more shares than they sold. You can see the insider transactions of GoodRX Holdings over the years.
Simply Wall St · 04/23 19:25
GDRX Alert: Rosen, Skilled Investor Counsel, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GDRX
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of GoodRx Holdings, Inc. Between September 23, 2020 and November 8, 2022. If you purchased GoodRX common stock during the Class Period, you may be entitled to compensation. A class action has already been filed. To join the goodRx class action, you must move the court by June 21, 2024.
Barchart · 04/23 10:03
GDRX INVESTOR ALERT: Kessler Topaz Meltzer & Check, LLP Files A Securities Fraud Class Action Lawsuit Against GoodRX Holdings, Inc. And Encourages Investors With Losses To Contact The Firm
Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against GoodRx Holdings, Inc. The lawsuit was filed on behalf of investors who purchased or acquired goodrx common stock between September 23, 2020, and November 8, 2022. Goodrx operates a price comparison platform for prescription drugs. The price of good rx stock plummeted 25% on May 9, 2022, when the company revealed Kroger could unilaterally refuse to accept its discounts.
Barchart · 04/22 16:04
Weekly Report: what happened at GDRX last week (0415-0419)?
Weekly Report · 04/22 09:28
Weekly Report: what happened at GDRX last week (0408-0412)?
Weekly Report · 04/15 09:25
Analysts Are Bullish on These Healthcare Stocks: GoodRx Holdings (GDRX), Arcutis Biotherapeutics (ARQT)
TipRanks · 04/12 10:40
R1 RCM, Health Catalyst downgraded as KeyBanc reviews health-tech space
R1 RCM, Health Catalyst downgraded as KeyBanc Capital Markets downgrades the stocks ahead of Q1 earnings. The firm upgraded GoodRx Holdings and Certara ahead of the healthcare IT space. The analyst cited the recent cybersecurity incident at UnitedHealth's Change Healthcare unit.
Seeking Alpha · 04/10 16:56
GoodRx Holdings Analyst Turns Bullish Ahead Of Q1 Earnings
GoodRx Holdings Inc (NASDAQ:GDRX) got an upgrade last month from Wells Fargo analyst. The stock was trading at a discount to its peers and its historical average, KeyBanc Capital Markets says. GoodRx's app downloads have been "encouraging," the analyst says.
Benzinga · 04/10 16:10
GOODRX HOLDINGS INC <GDRX.O>: KEYBANC RAISES OVERWEIGHT FROM SECTOR WEIGHT
Reuters · 04/10 10:10
GoodRx Holdings Raised to Overweight From Sector Weight by Keybanc
Dow Jones · 04/10 08:50
More
Webull provides a variety of real-time GDRX stock news. You can receive the latest news about Goodrx Holdings, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About GDRX
GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. It offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. It also equips healthcare professionals to find and prescribe affordable medications. It offers information and tools to help consumers compare prices and save on their prescription drug purchases. It operates a price comparison platform that provides consumers with geographically relevant prescription pricing and provides access to negotiated prices through its codes that can be used to save money on prescriptions across the United States (the prescription transactions offering). It also offers other healthcare products and services, including pharmaceutical manufacturer solutions, subscriptions, and telehealth services. Its subscription offerings provide additional benefits to consumers of its prescription transactions offering.